Thomas Strecker
Overview
Explore the profile of Thomas Strecker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Fischer K, Camara A, Troupin C, Fehling S, Strecker T, Groschup M, et al.
Transbound Emerg Dis
. 2019 Oct;
67(2):724-732.
PMID: 31627257
The genus Ebolavirus comprises several virus species with zoonotic potential and varying pathogenicity for humans. Ebolaviruses are considered to circulate in wildlife with occasional spillover events into the human population...
32.
Fries L, Cho I, Krahling V, Fehling S, Strecker T, Becker S, et al.
J Infect Dis
. 2019 Oct;
222(4):572-582.
PMID: 31603201
Background: Ebola virus (EBOV) epidemics pose a major public health risk. There currently is no licensed human vaccine against EBOV. The safety and immunogenicity of a recombinant EBOV glycoprotein (GP)...
33.
Strecker T, Nooh E, Weyand M, Agaimy A
J Card Surg
. 2019 Mar;
34(5):350-351.
PMID: 30908722
No abstract available.
34.
Timothy J, Hall Y, Akoi-Bore J, Diallo B, Tipton T, Bower H, et al.
Lancet Infect Dis
. 2019 Feb;
19(4):429-438.
PMID: 30799252
Background: To date, epidemiological studies at the index site of the 2013-16 west African Ebola outbreak in Meliandou, Guinea, have been restricted in their scope. We aimed to determine the...
35.
Poetsch J, Dahlke C, Zinser M, Kasonta R, Lunemann S, Rechtien A, et al.
J Infect Dis
. 2018 Nov;
219(4):556-561.
PMID: 30452666
In response to the Ebola virus (EBOV) crisis of 2013-2016, a recombinant vesicular stomatitis virus (VSV)-based EBOV vaccine was clinically tested (NCT02283099). A single-dose regimen of VSV-EBOV revealed a safe...
36.
Fischer K, Jabaty J, Suluku R, Strecker T, Groseth A, Fehling S, et al.
J Infect Dis
. 2018 Jul;
218(suppl_5):S305-S311.
PMID: 29982580
Many human ebolavirus outbreaks have been linked to contact with wildlife including nonhuman primates and bats, which are assumed to serve as host species. However, it is largely unknown to...
37.
Watanabe Y, Raghwani J, Allen J, Seabright G, Li S, Moser F, et al.
Proc Natl Acad Sci U S A
. 2018 Jun;
115(28):7320-7325.
PMID: 29941589
Lassa virus is an Old World arenavirus endemic to West Africa that causes severe hemorrhagic fever. Vaccine development has focused on the envelope glycoprotein complex (GPC) that extends from the...
38.
Palyi B, Magyar N, Henczko J, Szalai B, Farkas A, Strecker T, et al.
Emerg Microbes Infect
. 2018 Mar;
7(1):52.
PMID: 29593278
In 2013-2016, West Africa experienced the largest and longest Ebola virus disease outbreak ever documented. The wide geographic spread and magnitude of the outbreak often limited the timely and rapid...
39.
Whitmer S, Strecker T, Cadar D, Dienes H, Faber K, Patel K, et al.
Emerg Infect Dis
. 2018 Feb;
24(3):599-602.
PMID: 29460758
We describe a strain of Lassa virus representing a putative new lineage that was isolated from a cluster of human infections with an epidemiologic link to Togo. This finding extends...
40.
Agaimy A, Strobel D, Strecker T
Case Rep Pathol
. 2017 Nov;
2017:9403467.
PMID: 29158936
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare SMARCA4-driven aggressive malignancy of young age characteristically associated with paraneoplastic hypercalcemia. Comparable neoplasms/presentations have not been reported in...